Skip to main content
. 2023 Mar 2;15(3):814. doi: 10.3390/pharmaceutics15030814
5HT 5-hydroxytryptamine
ADSCs Adipose-derived mesenchymal stem cells
BBB Blood brain barrier
BDNF Brain-derived neurotrophic factor
CNS Central nervous system
CRP C-reactive protein
CSF Cerebrospinal fluid
DA Dopamine
DAT Dopamine transporter
DTI Diffusion tensor imaging
BBB Blood-brain barrier
EAAT Excitatory amino acid transporter
FGF-2 Fibroblast growth factor-2
fMRI functional MRI
FSL Flinders sensitive line
FST Forced swimming test
GDNF Glial cell line-derived neurotrophic factor
GNPs Gold nanoparticles
hiPSCs Human iPSCs
HUC-MSCs Human umbilical cord mesenchymal stem cells
iPSCs Induced pluripotent stem cells
LC Locus coeruleus
MDD Major depressive disorder
MI Myocardial Infarction
MRI Magnetic resonance imaging
MSCs Mesenchymal stem cells
NE Norepinephrine
NETs Norepinephrine transporters
NG Neurogenesis
NGF Nerve growth factor
NSCs Neural stem cells
NT 3-Neurotrophin-3
PGE2 Plasma prostaglandin E2
PTSD Post-traumatic stress disorder
SNRIs Serotonin-norepinephrine reuptake inhibitors
SPT Sucrose preference test
SSRIs Selective serotonin reuptake inhibitors
TLR Toll-like receptor
TRD Treatment-resistant depression
TST Tail suspension test
VGF nonacronymic